Background and aims: Magnesium sulfate has recently gained popularity as an adjuvant to general anesthesia. It acts as a blocker of N-methyl D-aspartate (NMDA) antagonist and hence may have a potential role in the prevention of postoperative pain. The aim of the present prospective, randomized, double-blind, and placebocontrolled study was to evaluate the efficacy of injection magnesium sulfate 50 mg/kg as premedication upon postoperative pain and analgesic requirement in patients undergoing elective laparoscopic cholecystectomy under general anesthesia.
INTRODUCTION
Pain is one of the most common and feared side-effect postoperatively. Postoperative pain is associated with not only adverse physiological but also psychological (posttraumatic stress disorder) sequelae. Unrelieved pain in the immediate postoperative period can also lead to the development of chronic pain, such as chronic postherniorrhaphy pain. Peripheral sensitization, chronic sensitization, and intraoperative nerve damage may singly or in combination act as the inciting causes for the above. On the contrary, an effective postoperative pain management not only retards the above adverse sequelae but also leads to early recovery, early mobilization, reduced hospital stay, and improved patient satisfaction. [1] [2] [3] [4] Opioids and nonsteroidal anti-inflammatory drugs (NSAIDs) are the most common analgesics used for the management of postoperative pain but are not devoid of side-effects. The goal of postoperative pain management is alleviation of pain, its associated suffering, and at the same time, minimizing the dose and the side-effects of the analgesics. [1] [2] [3] [4] [5] Preemptive analgesia that is administered prior to nociceptive stimulus prevents development of altered signal processing of afferent inputs from injuries. 6 A number of drugs, such as NSAIDs, opioids, N-methyl D-aspartate (NMDA) antagonists, alpha-2 receptor blockers, etc. have used as preemptive adjuvants so as to reduce the requirement of postoperative analgesics. Magnesium sulfate has been used since many years as an antiarrhythmic as well as for prophylaxis and treatment of seizures in preeclampsia and eclampsia respectively. [7] [8] [9] Among its numerous physiological actions, the ones that are most commonly exploited in the clinical practice include calcium channel antagonism, NMDA receptor antagonism, prevention of catecholamine release from adrenal jOrapain medulla, and nerve endings in response to stress. 7, [10] [11] [12] It has been proposed that magnesium sulfate owing to its calcium channel blocking and most importantly to NMDA receptor modulation might prevent establishment of surgery-induced altered sensory processing of afferent inputs. 1 Magnesium sulfate supplementation has been found to be beneficial in premenstrual syndrome and headache. 13, 14 Intrathecal magnesium sulfate has been found to induce spinal anesthesia in animal models and magnesium sulfate has been found to be used as an adjuvant to neuraxial and regional anesthesia in human trials with variable results. The existing literature on the effect of single-dose preemptive administration of magnesium sulfate on postoperative pain is equivocal with some studies demonstrating a beneficial effect while others demonstrating otherwise. [15] [16] [17] [18] Therefore, we designed this prospective, randomized, double-blind, and placebocontrolled trial to evaluate the effect of single-dose (50 mg/kg) administration of magnesium sulfate preoperatively on postoperative pain scores and analgesic requirement in patients undergoing laparoscopic cholecystectomies under planned general anesthesia.
MATERIALS AND METHODS
After obtaining approval from institutional ethics committee and written informed consent, 100 consecutive American Society of Anesthesiologists (ASA) grade I and II adult patients of age group between 18 and 60 years, of either sex undergoing laparoscopic cholecystectomy under planned general anesthesia were included in the study. Patients with uncontrolled hypertension, diabetes mellitus, cardiovascular, respiratory or renal comorbidities, allergy to any of the study drug and hypomagnesemia were excluded from the study. Pregnant and lactating mothers and patients who refused to participate in the study were also excluded. A thorough preanesthetic checkup inclusive of history, history of previous anesthetic exposure, physical, and airway examination were done preoperatively. All the necessary investigations, such as a complete hemogram, random blood sugar, and kidney function test were ordered and ensured to be within the normal values. Chest X-ray and electrocardiogram (ECG) were done in those older than 40 years of age. Patients with abnormalities in any of the abovementioned investigations were excluded from the study. The patients were kept fasting for 8 hours preoperatively and tablet alprazolam 0.25 mg was given the night before and at 6 am on the morning of the surgery. The patients were instructed on how to use numerical rating pain scale (NRS) in the preoperative period. On the day of surgery, the patients were wheeled into a preprepared operation theater, multichannel monitor was attached, and baseline vitals like heart rate (HR), noninvasive blood pressure (NIBP), and oxygen saturation (SpO 2 ) were recorded. An 18 gauge intravenous (IV) cannula was inserted into a peripheral vein on the dorsum of hand and connected to a ringer lactate drip. The patients were randomly assigned using a computergenerated random number list into one of the two groups to receive: Magnesium sulfate 50 mg/kg as 10% solution IV (group M) or an equal volume of normal saline IV (group C) 15 minutes prior to induction of anesthesia. The study solutions were prepared by an independent anesthesiologist in identical syringes labeled as the "study drug." After this, all the patients received injection fentanyl 2 µg/kg, thiopentone sodium 5 mg/kg, and succinyl choline 1.5 mg/kg IV. Endotracheal intubation was done with an appropriate-sized orotracheal tube and intermittent positive pressure ventilation commenced with isoflurane and nitrous oxide (N 2 O) in oxygen to maintain end tidal carbondioxide (EtCO 2 ) of 35 to 40 mm Hg. Anesthesia was maintained with isoflurane and N 2 O in oxygen and injection vecuronium bromide. The ECG, NIBP, and SpO 2 were monitored continuously and recorded at baseline, before intubation, after intubation, before and after creation of pneumoperitoneum, and subsequently at 5-minute intervals. Any episode of bradycardia defined as HR < 60 was recorded and treated with injection atropine 0.2 mg/kg IV. Any episode of hypotension defined as mean arterial pressure (MAP) <60 mm Hg or ≥ 20% fall from the baseline was treated with IV fluid bolus and injection mephenteramine 3 mg IV boluses. At the end of surgery, neuromuscular blockade was antagonized with injection neostigmine 0.05 mg/kg and vecuronium bromide 0.01 mg/kg IV. The patients were shifted to the post anesthesia care unit where they were assessed for HR, NIBP, SpO 2 , NRS, and any side-effect. The patients were assessed for pain using an 11-point NRS (0- The patients as well as the trained nurse involved in postoperative monitoring were unaware of the group allocation. Injection tramadol 1.5 mg/kg IV was administered as the rescue analgesic whenever NRS score was ≥ 7 and 24-hour consumption of tramadol was recorded.
Our primary outcomes were postoperative pain scores and total 24-hour tramadol consumption. Our secondary outcomes were the HR and systolic blood pressure (SBP) response to endotracheal intubation.
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Statistical Analysis
Statistical analyses were performed using SPSS 17.0 for Windows (Statistical Package for Social Sciences, Chicago, IL, USA). Continuous variables are presented as mean ± SD or median (range) for non-normally distributed data. Categorical variables are expressed as frequencies and percentages. The normally distributed continuous variables for both groups were compared using analysis of variance. Non-normal distribution continuous variables were compared using Kruskal-Wallis test. Nominal categorical data between the groups were compared using chi-squared test or Fisher's exact test as appropriate. For all statistical tests, a p-value of < 0.05 and 0.001 was taken to indicate a significant and highly significant difference respectively.
RESULTS
A total of 100 patients were recruited and completed the study. Both the groups were comparable with respect to demographic variables ( Table 1 ). The average age was 44.18 years in group C and 42.45 years in group M. The distribution of patients in the various age groups was also comparable among the groups ( Table 2 ). The baseline vitals were comparable among the groups (Table 3 ). An increase in mean heart rate after intubation was observed in both the groups but the increase was found to be statically more significant in group C (from 75.56 ± 10.081 to 95.58 ± 11.76 mm Hg) compared to group M (from 79.56 ± 14.934 to 89.28 ± 12.657 mm Hg) (Graph 1, p = 0.0114). The mean SBP increased in both the groups after intubation and after creation of pneumoperitoneum but when compared there was a statistically more significant increase in group C compared to group M (p = 0.003 and 0.009 respectively) ( Table 4 and Graph 2). The mean NRS was comparable among both the groups throughout the 24-hour postoperative period ( Table 5 ). The mean NRS was 5.307 ± 1.339 and 5.286 ± 1.601 in groups C and M respectively. The mean 24-hour tramadol requirement was also comparable among the groups being 246 ± 26 and 231.6 ± 15.6 mg in groups C and M respectively (p = 0.38). No episode of bradycardia, hypotension, or any other side-effect occurred in any of the groups.
DISCUSSION
Our study results show that single-dose (50 mg/kg) magnesium sulfate IV premedication prior to induction 20 The conflicting results might have been due to the above variations in the dose, regimens, and the chemical preparations of magnesium used by different authors. 20 Laryngoscopy and intubation leads to sympathetic stimulation and release of catechol amines which can lead to adverse hemodynamic responses like tachycardia, hypertension, and transient arrhythmias. 23, 24 Magnesium reduces the release of catecholamine from adrenal medulla and nerve endings in response to stress like laryngoscopy and intubation. 25, 26 We observed statistically significant increase in HR and SBP in response to endotracheal intubation in the control group compared to the magnesium sulfate premedication group. Similar stabilization of hemodynamics with respect to endotracheal intubation has been demonstrated by other authors as well. 27, 28 No episode of hypotension or bradycardia occurred in any of the groups in our study. The hypotension observed with magnesium sulfate is a manifestation of its calcium channel blocking action and subsequent vasodilation. This rarely occurs at doses less than 60 mg/kg. 1, 29 The lower doses of magnesium sulfate (50 mg/kg) used in our study might have been the reason behind the absence of hypotensive effect. Our results are in accordance with those of other authors.
1
LIMITATIONS
The main limitation of our study is that we did not measure serum magnesium levels. However, measurement of serum magnesium is an imperfect measure of total body magnesium, majority of which is intracellular and there is an imperfect correlation between them. 
CONCLUSION
We conclude by saying that magnesium sulfate 50 mg/kg IV premedication prior to induction of anesthesia is effective in attenuating the hemodynamic stress response to surgery but has no effect on the postoperative pain or the analgesic consumption. The use of 50 mg/kg magnesium sulfate is not associated with any side-effects.
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